Please join CTeD for their Bio-Entrepreneur Talk on Thursday, 30 May 2019, 3pm – 4pm at Duke-NUS Medical School, Meeting Room 7C, Level 7.
In this sharing session titled “Impact of the New Biology: from Genomics to Personalised Medicine”, we will hear from Dr Darrin M Disley OBE, CEO of Mogrify, Parallel Entrepreneur, Angel Investor and Enterprise Champion. Register at this link.
Life expectancy in most countries is increasing by one to five hours per day and this rate of change, especially in the developing world, will fundamentally change the lives of us all. We need to prepare ourselves for the higher costs for social services, labour, pension and healthcare costs that result from our ageing population.
The biggest issue of the next 50 years will be the affordability of healthcare. The current economics of producing medicines designed for treating diseases of ageing such as Alzheimer’s and Cancer is not scalable due to high development costs and low patient efficacy. Fortunately over the past two decades there a convergence of technology–hardware, wetware and software–that is allowing both the elucidation of the fundamental genetic basis of disease and also the implementation of a personalised approach to medicine. This approach combines early diagnosis, targeted molecular therapeutics and companion diagnostic tests to match the right drug(s) to the right patient as well as the recent arrival of gene and cell therapies capable of curing an individual patient’s disease.
In order for such treatment regimens to be implemented and reimbursed effectively and efficiently, patient data must be linked into this post-genomic medicine cabinet. This data will now include real-time health and wellness telemetry along with diagnostic tools that predict the onset, progression clinical outcomes of disease.
The meeting of the challenge requires development of technology platforms that can only be built via a holistic research and development approach that links computer, natural and physical scientists with chemical, electrical and mechanical engineers in an environment conducive to multidisciplinary interaction under the pressure of delivery to commercial, economic and societal timelines.
This talk will outline my vision of the future healthcare paradigm as the population ages and I will bring out the need to address this with multidisciplinary science, academic-industry partnership, open innovation models within an entrepreneurial ecosystem capable of exploiting the current favourable R&D, tax, regulatory and investment framework.
Kindly note that visitors to Duke-NUS will need to exchange for a visitor’s access card at the reception, in order to access the main lift lobby through a card reader.